Semira Sheikh
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review.
Journal: Biomedicines
Published: May 16, 2023
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives.
Journal: Biomedicines
Published: July 15, 2022
Transverse myelitis after anti-CD19 directed CAR T cell therapy for relapsed large B cell lymphoma.
Journal: EJHaem
Published: April 03, 2021
Addressing an Unmet Need in Relapsed or Refractory Hodgkin Lymphoma.
Journal: JCO oncology practice
Published: February 10, 2021
Prodrugs and prodrug-activated systems in gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 01, 2020
Belantamab mafodotin in the treatment of relapsed or refractory multiple myeloma.
Journal: Future oncology (London, England)
Published: September 03, 2020
COVID-19 Testing in Patients with Cancer: Does One Size Fit All?
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2020
Pembrolizumab for the treatment of diffuse large B-cell lymphoma.
Journal: Expert opinion on biological therapy
Published: August 29, 2019
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism.
Journal: Cancer research
Published: February 26, 2016
Deacetylation of chromatin and gene expression regulation: a new target for epigenetic therapy.
Journal: Critical reviews in oncogenesis
Published: March 10, 2015
Last Updated: 09/26/2026